Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

NCT03199963 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

223

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative - change in development strategy

Conditions

Mammographic Breast Density

Interventions

DRUG: 4-OH tamoxifen
DRUG: Placebo

Sponsor

BHR Pharma, LLC